Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AH Neuraminidase inhibitors
J05AH03 Peramivir
D03829 Peramivir (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-influenza Agents
Peramivir
D03829 Peramivir (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D03829 Peramivir (USAN/INN); Peramivir hydrate (JAN)
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02842 Neuraminidase inhibitor
D03829 Peramivir
Drug classes [BR:br08332]
Antiviral
DG03029 Anti-influenza virus agent
D03829 Peramivir
Antimicrobials [BR:br08307]
Antivirals
Virus release inhibitor
Neuraminidase inhibitor
D03829 Peramivir (USAN/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Virus release inhibitor
Neuraminidase inhibitor
D03829 Peramivir (USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03829
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03829
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03829
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03829